Nautilus Biotechnology Inc Ordinary Shares
North American company
Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Latest NAUT News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News